IPV 疫苗市場（按疫苗品牌、分銷管道和地區）—市場規模、佔有率、前景和機會分析（2025-2032）

2025 年全球 IPV 疫苗市場規模估計為 1.999 億美元，預計到 2032 年將達到 3.585 億美元，2025 年至 2032 年的複合年成長率為 8.7%。

數字。 2025年IPV疫苗各地區市場佔有率（%）

去活化脊髓灰質炎疫苗（IPV）也稱為索爾克疫苗。脊髓灰質炎疫苗有兩種：去活化脊髓灰質炎疫苗和口服脊髓灰質炎疫苗。 IPV 疫苗通常透過注射到手臂或腿部進行接種。

對雞蛋或鏈黴素等藥物過敏的人不應接受 IPV 注射。只有當疫苗接種者正在接受長期類固醇治療、患有癌症、正在接受化療或家中有未免疫的成年人時，才會進行 IPV。

預計到 2025 年全球 IPV 疫苗市場規模將達到 1.999 億美元，到 2032 年將達到 3.585 億美元，預測期內複合年成長率為 8.7%。

市場動態

為了防止脊髓灰質炎的爆發，各國政府正在採取舉措提高人們對疫苗接種的認知。公共部門組織已經實施了利潤豐厚的疫苗接種計劃，為貧困人口提供疫苗接種，預計這將為不久的將來全球去活化脊髓灰質炎疫苗 (IPV) 市場的成長創造非常有利的環境。例如，2020年9月，加納衛生服務局（GHS）啟動了一系列脊髓灰質炎疫苗接種/免疫宣傳活動，以防止病毒在高風險地區傳播。脊髓灰質炎疫苗接種宣傳活動正在加納所有地區為 2016 年 1 月至 2018 年 6 月期間出生的所有兒童接種去活化脊髓灰質炎疫苗 (IPV)。

研究的主要特點

• 本報告詳細分析了預測期（2025-2032 年）全球 IPV 疫苗市場規模和年複合成長率（CAGR%），假設 2024 年為基準年。
• 它揭示了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 全球 IPV 疫苗市場的主要企業根據公司概況、業績、產品系列、市場影響、分銷策略、關鍵發展、策略和未來計劃等參數進行分析。
• 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• IPV 疫苗市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 全球 IPV 疫苗市場分析中使用的各種策略矩陣將有助於相關人員做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件

第2章 市場概述

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 市場機會藍圖

第3章 關鍵見解

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• PEST分析
• 波特分析
• 公司市場佔有率分析
• 進出口分析
• 監管情景
• 定價分析
• COVID-19影響分析
• 流行病學
• 國家醫療費用支出
• 各國疫苗覆蓋率
• 生產能力
• 經銷商狀況
• 投資與資金籌措
• 競爭格局
• 熱圖分析

4. 2020-2032 年全球 IPV 疫苗市場（以疫苗品牌）

• 介紹
• 脊髓灰質炎疫苗（PFS/SD）
• 沙尼普
• Orix
• IPOL/IMOVAX
• 滅蟻靈

5. 2020-2032 年全球 IPV 疫苗市場（依疫苗類型）

• 介紹
• 聯合疫苗
• 單一疫苗

6. 2020-2032 年全球 IPV 疫苗市場（管瓶瓶型）

• 介紹
• 單劑量管瓶
• 5劑量管瓶
• 10劑量管瓶

7. 2020-2032 年全球 IPV 疫苗市場（按分銷管道）

• 介紹
• 公共
• 私人的

8. 2020-2032 年全球 IPV 疫苗市場（按地區）

• 介紹
• 北美洲
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東
• 非洲

第9章 競爭態勢

10. 公司簡介-全球IPV疫苗市場

• Sanofi
• Serum Institute of India Pvt. Ltd.
• Bharat BIoTech
• Merck & Co., Inc.
• GlaxoSmithKline
• AJ Vaccines A/S
• Panacea BIoTec
• Biken
• Sinopharm Group Co. Ltd.
• Nanolek
• IMBCAMS
• Sinovac BIoTech
• LG Chem
• Beijing Minhai Biological Technology Co., Ltd.
• Biological E Limited
• Section 10
• 興衰
• 分析師觀點
• 一致的機會地圖

第 11 章參考文獻與調查方法

• 參考
• 調查方法

Global Ipv Vaccines Market is estimated to be valued at USD 199.9 Mn in 2025 and is expected to reach USD 358.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Figure. Ipv Vaccines Market Share (%), By Region 2025

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at USD 199.9 Mn in 2025 and is expected to increase to US$ 358.5 Mn by 2032, registering a CAGR of 8.7% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2020, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:

• This report provides in-depth analysis of the Global IPV vaccines market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Global IPV vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The IPV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global IPV vaccines market

Detailed Segmentation:

• Global IPV Vaccines Market, by Vaccine Brand:
  • Poliovac (Pfs/Sd)
  • Shanipv
  • Poliorix
  • Ipol/Imovax
  • Polymilex
• Global IPV Vaccines Market, by Distribution Channel:
  • Private
  • Public
• Global IPV Vaccines Market, by Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • GlaxoSmithKline Plc
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • PT Bio Farma
  • AJ Vaccines

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccine Brand
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Vial Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
  • Market Scenario - Conservative, Likely, Opportunistic
• Market Opportunity Map

3. Key Insights

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Pest Analysis
• Porters Analysis
• Company Market Share Analysis
• Import-Export Analysis
• Regulatory Scenario
• Pricing Analysis
• COVID-19 Impact Analysis
• Epidemiology
• Healthcare Spending, by Country
• Vaccination Rate, by Country
• Manufacturing Capacities
• Distributors Landscape
• Investments & Funding
• Competitive Snapshot
• Heat Map Analysis

4. Global IPV Vaccines Market, By Vaccine Brand, 2020 - 2032 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032
  • Market Y-o-Y Growth Comparison (%), 2020 - 2032
  • Segment Trends
• POLIOVAC (PFS/SD), 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• SHANIPV, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• POLIORIX, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• IPOL/IMOVAX, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• POLYMILEX, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)

5. Global IPV Vaccines Market, By Vaccine Type, 2020 - 2032 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032
  • Market Y-o-Y Growth Comparison (%), 2020 - 2032
  • Segment Trends
• Combination Vaccine, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• Single Vaccine, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)

6. Global IPV Vaccines Market, By Vial Type, 2020 - 2032 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032
  • Market Y-o-Y Growth Comparison (%), 2020 - 2032
  • Segment Trends
• 1 Dose Vial, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• 5 Dose Vial, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• 10 Dose Vial, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)

7. Global IPV Vaccines Market, By Distribution Channel, 2020 - 2032 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032
  • Market Y-o-Y Growth Comparison (%), 2020 - 2032
  • Segment Trends
• Public, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• Private, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)

8. Global IPV Vaccines Market, By Region, 2020 - 2032 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Million)
  • Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Million)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest Of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Asean
    • Rest Of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
    • GCC
    • Israel
    • Rest Of The Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Million)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Competitive Snapshot
• What Market Participants are Saying?
• Competitive Dashboard
• Company Market Share Analysis, 2025 - Global

10. Company Profiles - Global IPV Vaccines Market

• Sanofi*
  • Company Overview
  • Product/Service Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategic Overview
• Serum Institute of India Pvt. Ltd.
• Bharat Biotech
• Merck & Co., Inc.
• GlaxoSmithKline
• AJ Vaccines A/S
• Panacea Biotec
• Biken
• Sinopharm Group Co. Ltd.
• Nanolek
• IMBCAMS
• Sinovac Biotech
• LG Chem
• Beijing Minhai Biological Technology Co., Ltd.
• Biological E Limited.
• Section 10: Wheel of Fortune
• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact